Back | Next |
home / stock / immvf / immvf message board
Subject | By | Source | When |
---|---|---|---|
tiny little gem here, main listening is at | xr_biotech_consult | investorshub | 07/08/2015 4:29:18 PM |
Albert Scardino of Immunovaccine Inc. : | xr_biotech_consult | investorshub | 07/08/2015 4:27:09 PM |
IMMUNOVACCINE AND PHARMATHENE SIGN EXCLUSIVE WORLDWIDE LICENSE AGREEMENT | xr_biotech_consult | investorshub | 07/08/2015 4:24:20 PM |
Immunovaccine releases DPX-Survivac clinical results | xr_biotech_consult | investorshub | 07/08/2015 4:23:11 PM |
Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine | xr_biotech_consult | investorshub | 07/08/2015 4:21:59 PM |
Incyte and Immunovaccine team up in ovarian cancer | xr_biotech_consult | investorshub | 07/08/2015 4:20:04 PM |
L2's are thin. It has great potential. | Sunnyjoe234 | investorshub | 05/18/2015 5:37:03 PM |
Seel, Please do let us know what | someconcerns | investorshub | 03/07/2014 12:55:42 AM |
Well that is intriguing. I think I need | Seel | investorshub | 03/05/2014 11:16:26 PM |
One trade, 50k. Somebody is buying all | noretreat | investorshub | 03/05/2014 6:18:53 PM |
Well that is certainly true. I am not | Seel | investorshub | 03/05/2014 12:19:14 AM |
But, then again with a volume of 4K | Ovidius | investorshub | 03/04/2014 7:47:39 AM |
That is quite a spike. I can't find | Seel | investorshub | 03/03/2014 11:54:02 PM |
Someone just picked up my shares for a | noretreat | investorshub | 03/03/2014 3:10:49 PM |
Oh my god - you are cracking me up! | Seel | investorshub | 02/22/2014 1:35:16 AM |
I would not want anyone to get the | noretreat | investorshub | 02/22/2014 12:07:28 AM |
No worries noretreat! It was a funny comment! | Seel | investorshub | 02/22/2014 12:01:46 AM |
That was not a serious comment, just in | noretreat | investorshub | 02/21/2014 11:53:40 PM |
I always (ALWAYS!) chase the women who think | noretreat | investorshub | 02/21/2014 11:29:10 PM |
Think you're going to get away from us | Seel | investorshub | 02/21/2014 9:59:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Immunovia AB Company Name:
IMMVF Stock Symbol:
OTCMKTS Market:
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...